Venker Eric's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Oct 17, 2025
- Accession no.
- 0001140361-25-038545
- Filed
- Oct 17, 2025
- Trade date
- Oct 15-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $14.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venker EricCIK 0001801917 | Officer (President & Immunovant CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Common Shares | MOption exerciseAcquired | +414,683 | $15.85 | +$6,572,725.55 | 1,919,642 | Direct | |
| Oct 15, 2025 | Common Shares | SSaleDisposed | −414,683 | $16.93 | −$7,020,583.19 | 1,504,959 | Direct | |
| Oct 16, 2025 | Common Shares | MOption exerciseAcquired | +318,282 | $15.85 | +$5,044,769.7 | 1,823,241 | Direct | |
| Oct 16, 2025 | Common Shares | SSaleDisposed | −318,282 | $17.05 | −$5,426,708.1 | 1,504,959 | Direct | |
| Oct 17, 2025 | Common Shares | MOption exerciseAcquired | +118,418 | $15.85 | +$1,876,925.3 | 1,623,377 | Direct | |
| Oct 17, 2025 | Common Shares | SSaleDisposed | −118,418 | $17.06 | −$2,020,211.08 | 1,504,959 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Common Stock | MOption exerciseDisposed | −414,683 | $0.00 | $0 | 436,700 | Direct | |
| Oct 16, 2025 | Common Stock | MOption exerciseDisposed | −318,282 | $0.00 | $0 | 118,418 | Direct | |
| Oct 17, 2025 | Common Stock | MOption exerciseDisposed | −118,418 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.